Af­ter ap­provals for one of can­cer's 'un­drug­gable' tar­gets, re­search in­to new KRAS ther­a­pies booms: #AACR24

For can­cer re­searchers, the po­ten­tial was as ob­vi­ous as the prob­lem.

Mu­ta­tions to the KRAS gene dri­ve near­ly a third of all can­cers. A laun­dry …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.